Page last updated: 2024-12-07
4'-bromophenacyl triflate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 125008 |
| SCHEMBL ID | 14351624 |
| MeSH ID | M0128192 |
Synonyms (22)
| Synonym |
|---|
| bptse |
| [2-(4-bromophenyl)-2-oxoethyl] trifluoromethanesulfonate |
| 2-(4-bromophenyl)-2-oxoethyl trifluoromethanesulfonate |
| 93128-04-2 |
| methanesulfonic acid, trifluoro-, 2-(4-bromophenyl)-2-oxoethyl ester |
| A844454 |
| FT-0642235 |
| 4'-bromophenacyl trifluoromethanesulfonate |
| 4'-bromo-2-hydroxyacetophenone trifluoromethanesulfonate ester |
| 4'-bromophenacyl triflate |
| 4-bromophenacyl trifluoromethanesulfonate |
| 4-bromophenacyl triflate |
| SCHEMBL14351624 |
| AKOS016845945 |
| DTXSID80239290 |
| methanesulfonic acid,1,1,1-trifluoro-, 2-(4-bromophenyl)-2-oxoethyl ester |
| 4-bromophenacyl trifluoromethanesulfonate, for hplc derivatization, >=95% (h-nmr/c-nmr) |
| 4-bromophenacyl-trifluoromethanesulfonate |
| 4-bromophenacyl trifluoro-methanesulfonate |
| mfcd00467440 |
| 2-(4-bromophenyl)-2-oxoethyltrifluoromethanesulfonate |
| ymykwfclilhejb-uhfffaoysa-n |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.77
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.77) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||